Masimo | MASI - Operating Profit

Stock Price
137.64
Daily Change
-1.49 -1.07%
Monthly
2.72%
Yearly
-22.65%
Q1 Forecast
133.10

Masimo reported $83.6M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Align Technology USD 184.65M 21.61M Sep/2025
AtriCure USD 208K 4.03M Sep/2025
Avanos Medical USD 18.97M 72.63M Sep/2025
Baxter International USD 201.2M 70.8M Sep/2025
Becton, Dickinson and Co. USD 826M 153M Sep/2025
Boston Scientific USD 1.04B 98M Sep/2025
Dexcom USD 242.5M 29.9M Sep/2025
Edwards Lifesciences USD 425.1M 5.8M Sep/2025
General Electric Aerospace USD 1.77B 536M Dec/2025
Globus Medical USD -117.52M 8.43M Sep/2025
Haemonetics USD 58.49M 12.35M Sep/2025
Insulet USD 117.7M 3.4M Sep/2025
Integra LifeSciences USD 11.76M 13.07M Sep/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
Masimo USD 83.6M 19.1M Sep/2025
Medtronic USD 1.7B 100M Sep/2025
Owens Minor USD 56.75M 56.63M Jun/2025
ResMed USD 497.6M 35.25M Dec/2025
Steris USD 270.9M 45.6M Sep/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD -22.86M 9M Sep/2025
Teleflex USD -408.9M 586.38M Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Zimmer Biomet Holdings USD 338.3M 58.1M Sep/2025